<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30316463</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1557-9786</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>26</Volume>                    <Issue>4</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                    </PubDate>                </JournalIssue>                <Title>Magnetic resonance imaging clinics of North America</Title>                <ISOAbbreviation>Magn Reson Imaging Clin N Am</ISOAbbreviation>            </Journal>            <ArticleTitle>Whole-Body Magnetic Resonance Imaging in Oncology: Uses and Indications.</ArticleTitle>            <Pagination>                <MedlinePgn>495-507</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S1064-9689(18)30043-6</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mric.2018.06.003</ELocationID>            <Abstract>                <AbstractText>Whole-body MRI (WB-MRI) has emerged as a radiation-free method for the diagnosis, staging, and therapy response assessments in cancer patients. This article reviews the current roles for WB-MRI in the clinical context of limitations of currently used techniques, focusing on bone marrow disease applications. Indication for broader clinical use are discussed, including guideline recommendations. The emerging screening role of WB-MRI in subjects at high risk of cancer is discussed, as is normal population screening.</AbstractText>                <CopyrightInformation>Copyright Â© 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Petralia</LastName>                    <ForeName>Giuseppe</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, IEO - European Institute of Oncology IRCCS, Via Ripamonti, 435, Milan 20141, Italy; Department of Oncology and Hematology, University of Milan, Via Festa del Perdono 7, Milan 20122, Italy. Electronic address: giuseppe.petralia@ieo.it.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Padhani</LastName>                    <ForeName>Anwar R</ForeName>                    <Initials>AR</Initials>                    <AffiliationInfo>                        <Affiliation>MR unit, Paul Strickland Scanner Centre, Mount Vernon Hospital, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Magn Reson Imaging Clin N Am</MedlineTA>            <NlmUniqueID>9422762</NlmUniqueID>            <ISSNLinking>1064-9689</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Bone marrow disease</Keyword>            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Lymphoma</Keyword>            <Keyword MajorTopicYN="N">Melanoma</Keyword>            <Keyword MajorTopicYN="N">Multiple myeloma</Keyword>            <Keyword MajorTopicYN="N">Prostate cancer</Keyword>            <Keyword MajorTopicYN="N">Response assessment</Keyword>            <Keyword MajorTopicYN="N">Whole-body-MR Imaging</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30316463</ArticleId>            <ArticleId IdType="pii">S1064-9689(18)30043-6</ArticleId>            <ArticleId IdType="doi">10.1016/j.mric.2018.06.003</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>